Hiroki Yokoyama

13PUBLICATIONS
30CO-AUTHORS
Exercise physiologyMajor global burdens of diseaseFood properties (incl. characteristics and health benefits)PharmacogenomicsEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 08, 2026
Phase angle, extracellular to intracellular water ratio, and advanced glycation end products according to four sarcopenia categories and in relation to muscle strength/mass in elderly out-patients with diabetes.

|May 15, 2023
Impact of COVID-19 pandemic on behavioral changes and glycemic control and a survey of telemedicine in patients with diabetes: A multicenter retrospective observational study.

Ryotaro Bouchi, Takehiro Sugiyama, Atsushi Goto

|Jun 23, 2022
The renoprotective effect of once-weekly GLP-1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67).

Ken-Ichi Tsuchida, Shinji Taneda, Isao Yokota

|May 03, 2022
Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66).

Hiroki Yokoyama, Shin-Ichi Araki, Katsuya Yamazaki

|Jul 01, 2021
Combined changes in albuminuria and kidney function and subsequent risk for kidney failure in type 2 diabetes.

Megumi Oshima, Tadashi Toyama, Akinori Hara

|Jun 30, 2021
Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61).

Noriharu Yagi, Ichiro Komiya, Keiko Arai

Pageof 3

Frequent Collaborators

2 joint publications

Aika Miya

2 joint publications

Akinobu Nakamura

2 joint publications

Kyu Yong Cho

2 joint publications

Kazuhisa Tsuchida